MDS is a bone marrow failure disorder
MDS is a blood cancer
Learn More >

MDS Professional Report

This podcast series provides important up-to-the-minute information on MDS including diagnosis, treatment and clinical research.

The explosion of information on MDS forces us to seek novel, alternative ways to distribute it.  Podcasts gives us an easy and popular way to communicate this information in a short time.

Subscribe!

  • Listen on Spotify
  • Season 2
    • Welcome to season 2 of the MDS Professional Report. We look forward to your feedback!

      Episode 3:

      Pediatric MDS

      Prof. Shimamura

      Prof. Akiko Shimamura (Harvard Medical School, Boston), Guillermo Sanz (Valencia) and Moshe Mittelman (Tel Aviv) discuss the features of childhood MDS, and the differences between pediatric and adult primary MDS.

    • Welcome to season 2 of the MDS Professional Report. We look forward to your feedback!

      Episode 2:

      The role of genetics in MDS management

      Drs. Rafael Bejar

      Drs. Rafael Bejar (San Diego) and Moshe Mittelman (Tel Aviv) discuss several papers highlighting the role of genetics in MDS diagnosis, follow up and prediction of treatment. They also discuss the role of the newly approved luspatercept in the treatment of anemic transfusion-dependent patients with lower-risk MDS

    • Welcome to season 2 of the MDS Professional Report. We look forward to your feedback!

      Episode 1:

      MDS in ASH 2021 – Are We Already in the Molecular Era?

      Dr. Moshe Mittelman and Dr. Drorit Merkel

      Drs. Moshe Mittelman, of The Tel Aviv Sourasky Medical Center, and Drorit Merkel, of the Sheba Medical Center, both from Tel Aviv University, Israel, discuss several important presentations from the recent 2021 ASH meeting.



Thank you to Bristol-Myers Squibb and Gamida Cell for supporting this initiative.

Review answers to commonly asked questions or get answers to your questions from an MDS expert